Speed to the clinic and patient safety are important goals when working to bring novel genetic therapies to patients. To achieve these goals, Homology Medicines decided to invest in internal development and manufacturing operations not long after the Company’s founding, which included the construction of a 25,000 sq ft GMP manufacturing facility adjacent to its […]
About Alex Meola
Alex Meola is a Scientist II in the Downstream Process Development group at Homology Medicines. He has a degree in Biochemistry & Biophysics from Rensselaer Polytechnic Institute and has experience working in downstream process development, formulation development, and manufacturing. His experience includes developing processes to purify complex drug modalities including AAVs, nanoparticles, liposomes, and recombinant proteins.